A pharmacy group operating in London and the surrounding areas has said it's cliched a financial deal worth £4.25 million with a major global bank to bolster
its mergers and acquisitions activity.
Osbon Pharmacy Group said on Monday (19 June) that it would use the multi-million-pound funding package from HSBC UK to also invest in bringing accessible and
comprehensive medical services closer to the doorstep of Londoners and people of South East England.
The family-run business said the new money will open new position which will include opportunities for pharmacists, pharmacy assistants, pharmacy technicians,
dispensers, accounts clerks and delivery drivers, taking the company's total headcount to 185.
The group, which currently has 26 pharmacies across London and South East England, was established in 2005.
The company offers a range of medicine and prescription services as well as offering customary help and advice. It switched to banking with HSBC UK last year as
part of a £6.9M refinance package, which saw the business acquire nine pharmacies and takes the total funding provided by HSBC UK to date to £11.1m.
Former Prime Minister Theresa May has formally opened new offices of LEO Pharma UK and Ireland during a launch event in Maidenhead, Berkshire.
The company said on Friday (June 16) that the new building, based at Foundation Park, will function as its UK and Ireland operational headquarters.
LEO Pharma has been manufacturing dermatology products in the UK and Ireland for over 60 years and continues its commitment to the Maidenhead area, where it been
based for 10 years. The grounds offer state-of-the-art facilities and a greener and more sustainable workplace, the company said and hoped that that strong transport
connections at Foundation Park will allow for seamless international collaboration, while a range of health and wellness initiatives will contribute to employee
wellbeing.
This new space will enable a collaborative and flexible work environment for LEO Pharma staff, ensuring they can continue to work to improve the lives of people
living with skin conditions, their families and society.
An urethroplasty, also known as a urethral reconstruction, is an open surgical treatment to repair a urethral stricture. Not like urethral dilations or incisions of the stricture, urethroplasty surgical treatment is an open operation with an incision of the skin and direct urethral stricture repair.
Community Pharmacy England (CPE) to host a Parliamentary drop-in event in July to brief MPs and Peers about the ongoing medicines supply chain issues that
are negatively affecting pharmacies and their patients across the country.
CPE's Pressures Survey earlier this year highlighted the extent of both the operational and financial impacts of medicines supply issues on pharmacy businesses,
therefore it has continued to hear from both pharmacy owners and others about the problems.
The event aims to ensure that MPs understand the problems and their impact on pharmacies.
Peter Dowd MP is hosting the event, joined by representatives from Community Pharmacy England, the Nuffield Trust, patient groups and more.
The event will also be another opportunity to talk to MPs from across the political spectrum about the very serious situation that community pharmacies still find
themselves in and the need for further investment in the sector.
Janet Morrison OBE, Chief executive of Community Pharmacy England said: "The results of our Pressures Survey earlier this year showed just how much supply issues
are continuing to negatively impact pharmacy businesses and all those who work in them. The survey found that almost all pharmacy owners (97%) are facing
significant increases in wholesaler and medicine supply issues, with 71% saying this was leading to delays in prescriptions being issued.
Covid-vaccine maker AstraZeneca said Friday that profits fell sharply in the first half on ballooning costs linked to its takeover of US biotech firm Alexion.
The pharmaceutical group added that sales of its Covid-19 vaccine Vaxzevria slumped 49 percent in the second quarter.
Net profit slumped 64 per cent to $746 million compared with the first six months of last year, AstraZeneca said in a statement.
Operating expenses jumped 33 percent, "reflecting the addition of Alexion, and continued investment in new launches and the pipeline" of drugs, the group said.
That offset a 48-percent jump in revenue to more than $22 billion.
Revenue rose strongly thanks to sales of Alexion medicines.
The group said annual revenue from Covid-19 medicines is anticipated to be broadly flat compared with 2021.
The Pharmacists' Defence Association has called on the Scottish government to end unnecessary pharmacy closures and introduce emergency regulations to force
companies that operate Scotland's pharmacies to open on the days and hours they have agreed.
It is concerned that decisions made by some health boards in Scotland have now allowed pharmacy owners to close their pharmacies on Saturdays.
The PDA is worried that a pharmacy closure could have negative impact on patients and other parts of the NHS, including neighbouring pharmacies, addiction and mental
health services, and minor injury and A&E units.
The association claims that there are record numbers of registered pharmacists who are available to work and therefore a decision to close a pharmacy over staff
shortages is misleading.
"The business owners may claim there is a shortage of pharmacists, but when they actively cancel agreed hours of work it does not suggest there is a shortfall of
workers," said the PDA, adding: "These business decisions often include closing their pharmacies at very short notice, even when pharmacists are available and willing
to work."
Shoulder pain is one of the most common types of pain that impacts your mobility and daily activities. Often associated with heart disease, shoulder pain can
also occur due to an injury, trauma, or a medical condition like arthritis. While over-the-counter medications might help relieve the pain, it is crucial to address
the cause of the pain becoming frequent. In this guide, we will be sharing particular situations that require a visit to an orthopedic doctor so you can get the
appropriate treatment.
AFTER AN ACCIDENT
Minor injuries and accidents can cause inflammation and pain at the injury site which can be resolved by taking OTC medications and giving the body time to heal.
However, in severe injuries, the joint may get swollen in an instant, cause extreme pain, or may seem deformed. In situations like these, there is a likelihood
of a fracture and the injury then needs to be evaluated by a specialist.
Depending on the severity of the accident, either the shoulder will be immobilized or operated on to repair the damage. If you have a broken shoulder, get plenty
of rest, eat healthily, and follow your doctor's instructions for a quick recovery.
More than 80 per cent of pharmacy organisations have received the Department for Work and Pensions (DWP) functionality for Real Time Exemption Checking (RTEC).
The NHS Business Services Authority (NHSBSA) has confirmed RTEC has been rolled out gradually, in phases. Contractors first received RTEC for use with processing
NHSBSA exemptions.
RTEC allows pharmacy teams to digitally check if patients are eligible for free NHS prescriptions because they hold a specific exemption. The rollout of the DWP
inclusion in RTEC means patients found to be exempt via RTEC no longer need to complete an exemption declaration on an EPS token, saving time for patients and
pharmacy teams.
David Broome, a community pharmacy contractor in Leeds and PSNC regional representative said: "The rollout of the DWP for our pharmacy team has been a positive
development, helping reduce the amount of paperwork that my team and patients have to deal with and in turn the environmental impact of our operations. Whereas I
used to send my paperwork bundle to the NHSBSA in a large box, I now send this in an envelope!"
Contractors can access and confirm their acceptance of the RTEC user agreement via the RTEC registration form in the NHSBSA's Manage Your Service (MYS) portal.
The Pharmaceutical Services Negotiating Committee (PSNC) has initiated the process for the regional representative election for the North-East and Cumbria
region after Mark Burdon's resignation from the committee earlier this year.
The North-East and Cumbria region covers Community Pharmacy County Durham, Community Pharmacy Cumbria, Gateshead and South Tyneside LPC, North of Tyne LPC,
Sunderland LPC and Tees LPC.
PSNC said that Pharmacists who are independent chemists and members or officers of these LPCs are eligible to stand for election as a new regional representative.
"An independent chemist is defined in the PSNC constitution as a chemist operating retail pharmacy businesses' from no more than nine premises in England from which
NHS Pharmaceutical Services or Local Pharmaceutical Services are provided and a person who is not a member of the Association of Independent Multiple pharmacies
(AIMp)," said PSNC.
The following PSNC briefing sets out the election process and the actions required by those seeking to stand for election.
Community pharmacists are readily accessible healthcare providers and medicine experts in the community setting and their counsel is often sought by patients
and consumers on a number of subjects including the use of dietary supplements. Their role in the sale of and advice regarding natural health and drug alternatives
has never been more relevant.
The recent National Health Service (NHS) Interim People Plan calls for the NHS to put all staff front and centre of the way it operates and identifies pharmacists
as a critical part of multidisciplinary teams, providing care across a wide range of increasingly complex patient needs.
Despite existing demand to counsel patients on a vast range of medicines, more and more consumers are looking to their pharmacist to support and enhance their
knowledge regarding the relevance of a growing range of supplementary nutrients now available.
Nutritional supplementation is increasingly becoming the consumer's first choice for 'drug free' treatment or natural prevention that provides a true sense of
taking control, which the prescription process often denies them.
Historically the immense benefits provided by the NHS have instilled a general abdication of our personal health control, leaving us to rely on the health service
to treat and cure as necessary.
As our NHS has become visibly over-stretched we begin to realise what the rest of the world has known for centuries - good health is based primarily upon nutritional
robustness. It may be stating the obvious but there is an excellent source of incremental revenue for the pharmacist who is willing to provide space to and advice
for nutritional supplements.
Healthcare has a strong relationship with technology. The modern structure of hospitals and medical facilities cannot function without the progress of
technology. It is important to acknowledge the impact of technology to ensure that priority is given to the constant maintenance of innovation. Here are a few
ways to understand how healthcare and technology operate together.
TECHNOLOGICAL INNOVATIONS KEEPING UP WITH MEDICAL DEMANDS
Healthcare has become increasingly dependent upon technology throughout the years. There is an almost infinite amount of equipment and machinery that is used on a
day-to-day basis to help facilitate the care of patients. One aspect that needs to be acknowledged is the prevalence of smart technology within the hospital and
healthcare spaces. Technology is being innovated, and it is only a matter of time until hospitals see such advancements be applied more often, as funding increases
alongside the development of new machinery and equipment. These include the inclusion of artificial intelligence in order to assist and supplement healthcare
professionals to do a better and more efficient job, providing better care for patients. Of course, such technology will need to follow trends of other industries
first to ensure its safe use and application when dealing with patients.
Pharmacy2U has recently acquired LloydsDirect in a confidential deal, bringing together two of the UK's foremost online pharmacies. Over time, both entities
will integrate their operations under the Pharmacy2U brand, the companies said in a joint statement.
The two businesses complement each other effectively, and their teams will now work closely together to uphold the patient-centric approach and service quality
for which both are known individually, the statement added. However, there is currently limited clarity regarding the sale process and its impact on Lloyds staff.
According to NHS Business Services Authority data from PharmData, Pharmacy2U dispensed 1,528,436 items in June 2023, while LloydsDirect, previously owned by
LloydsPharmacy, dispensed 1,142,891 items. This positions them as the top two online prescription pharmacies for items dispensed, with Well.co.uk in third place
at 128,691 items.
The British Generic Manufacturers Association has backed the UK government's proposed changes to the Statutory Scheme for branded medicines, which includes
a 'Life Cycle Adjustment' (LCA) mechanism to permit a lower rebate rate for medicines sold in competitive markets. The association underscored the necessity for
crucial amendments to forestall unintended consequences and ensure a practical alignment with market operations.
A precisely tailored approach is crucial in ensuring sustainability and growth in this sector, the BGMA said in a statement on Oct. 11. The Department of Health
and Social Care is currently working on the successor to the 2019 voluntary scheme for branded medicines and pricing access (VPAS) agreement, slated to end in 2023.
Negotiations for this successor, scheduled to begin on January 1, 2024, are already underway.
"We are pleased that the Statutory Scheme consultation recognises that branded generic and biosimilar medicines are subject to different market dynamics and
competitive pressures," said Mark Samuels, Chief Executive of BGMA. "As such, a one-size-fits-all approach across all branded products is not suitable for the
next five years. It is crucial to adopt a precisely tailored approach to this sector, ensuring both sustainability and growth."
Lloyds Pharmacy announced the withdrawal of pharmacy services from all Sainsbury's stores over mounting "industry pressures" faced by the community pharmacies.
The company had 77 branches at the beginning of this year - out of which five branches closed their doors and transferred the ownership of the remaining 72 to others.
It was announced in June this year that Lloyds Pharmacy branches in Sainsbury's will close its operation throughout 2023.
The following decision came after "changing market conditions" put 2,000 jobs on the line across the UK.
Four Lloyds Pharmacies inside Wales Sainsbury's stores closed within days of the announcement and one in the Roath suburb of Cardiff as well.
The remaining 72 changed hands as confirmed by the figures obtained by WalesOnline on 5 October.
The Department of Health and Social Care (DHSC) has created a new NIHR Research Delivery Network (RDN) to support the successful delivery of health and
social care research in England.
The network, which will start operating from next year, will play a critical and active role in implementing government policies.
It will support in implementing the Life Sciences Vision, the Future of UK Clinical Research Delivery vision, and policy for life sciences research and development.
The new network would be mainly working on growing the amount of commercial clinical research as its key strategic ambition.
Also, NIHR RDN will be responding to the findings of the Lord O'Shaughnessy review, which set out a clear blueprint for how the UK can return to its global
leadership role.
American healthcare technology company Omnicell has appointed Edward Platt as the new Senior Commercial Director of its UK community pharmacy division.
Along with this new role, Edward, who joined Omnicell in 2015, will continue his current leadership remit for Omnicell's UK & Ireland hospital division.
He will be leading a revamped commercial team, which would be responsible for increasing Omnicell's footprint of automation and consumable solutions delivered into
UK community pharmacies.
As part of the revamp, the company has created dedicated specialist teams to ensure the needs and challenges of community pharmacists (small independents and small
multiple operators) can be fully understood and supported.
The British Generic Manufacturers Association (BGMA) has elected Matthew Salzmann, UK Country Manager at Viatris, as its new Vice-Chair with immediate effect.
He will replace the current chair of the BGMA, Diane DiGangi-Trench, who is the UK country head for Sandoz.
Salzman, who is originally from Australia, has served approximately 1 billion patients worldwide last year as the UK Country Manager at Viatris, a global
pharmaceutical company operating in 165 countries.
In his role as BGMA Vice-Chair, Salzmann would focus on working in partnership with key stakeholders - the NHS, healthcare professionals, policy makers,
clinical societies, patient associations, academia - to ensure access to affordable and sustainable medicines for patients and the NHS.
Online pharmacy Pharmacy2U, acquires LloydsDirect in a merger for a single digital-first pharmacy.
The companies issued a statement on 9 October and confirmed that they would operate as Pharmacy2U.
It would also have a total of 1.4 million EPS nominations, as confirmed by NHS recent data.
They are planning to enhance patient accessibility to online pharmacy and healthcare services through their combined services.
Kevin Heath, Chief Executive Officer of Pharmacy2U, said: "We are delighted to welcome the LloydsDirect team into the Pharmacy2U family. Combining the best
of both of our businesses, we can provide patients with greater access and convenience.
The University friends purchased the North London pharmacy for a confidential sum.
Nabeel Patel, a GP pharmacist at Haringey GP Federation and Huseyin Akpinar, a former councillor at Enfield Council bought it following a confidential sales
process with Mark Page at Christie & Co.
Kiran and Nita Patel, who have owned and operated Beautychem Pharmacy since 1989, have decided to retire.
They claimed that the pharmacy had "dispensed an average of 6,576 items per month".
Kiran Patel, former owner of Beautychem Pharmacy, said: "It's been a pleasure serving the Tottenham community over the last 34 years. Over the years, we've seen
many changes in the pharmacy profession, but the constant has been the customers and the respect they have for what each independent pharmacy does for them.
The Department of Health and Social Care (DHSC) announced that free COVID-19 lateral flow tests will be supplied through community pharmacies for at-risk groups.
The service will operate from 6 November for patients aged over 12 years who are at risk of developing severe COVID-19 symptoms.
Community pharmacies that have participated in this new initiative will be paid £4 plus VAT for each box of five lateral flow device test kits provided.
Alastair Buxton, Director of NHS services at Community Pharmacy England said: "This is not going to be a high-volume service, but community pharmacy teams
are well placed to provide LFD test kits to eligible patients with them having made over 25.5 million supplies of COVID-19 LFD test kits in 2021/22.